BioNTech, CureVac claim bulk of Germany’s €750m COVID-19 vaccines fund
Regeneron tests COVID-19 antibody therapy in UK’s RECOVERY trial
NIH ‘very concerned’ about serious side effect in AstraZeneca's PhIII Covid-19 trial
Beyond the Spike: The COVAXX Approach to a COVID-19 Vaccine
Moderna or BioNTech: J.P. Morgan Lays Odds On the Race to a COVID-19 Vaccine
Dynavax Scores Supply Deal For Valneva’s Covid-19 Vaccine; Street Bullish
A bifidobacterial protein that can reduce inflammation in COVID-19 found by a RUDN geneticist
Cytiva Plans $500M Expansion, 1,000 New Hires Worldwide
MIS-C is a rare but dangerous illness striking children weeks after they get COVID-19 – here's what we know about it
Antibody test developed for COVID-19 that is sensitive, specific and scalable
Covid-19 roundup: NIH spotlights blood thinners in its next big trial; All it took was a pandemic to get JPM out of SF
GSK and J&J alum Vijay Reddy to take control of R&D at Tmunity; Andrew Hirsch exits Agios for CEO job at C4 Therapeutics
Munk Debates: Scientific Community Has Over-Reacted To COVID-19 Threat (& The Data Proves It)
Is Inovio Stock a Buy Right Now? This Is What You Need to Know
Antibody responses in COVID-19 patients could guide vaccine design
A primer on viruses, vaccines, and therapies
Study takes us a step closer to a universal antibody test for COVID-19
Exclusive: Ginkgo teams with unknown upstart in hunt for Covid-19 antibody
FL56+FL57= infinite possibilities? Flagship's hybrid startup takes machine learning in drug discovery to the next level — and Covid-19 offers a quick test
Non-vaccine nasal spray could protect against COVID-19
Unique partnership advances revolutionary CRISPR in a Box educational gene editing kit
What we know about MIS-C, a rare but dangerous illness striking children weeks after they get COVID-19
Pfizer, BioNTech Set To Supply EU With 200M Covid-19 Vaccine Doses
Scientists develop low-cost chip to detect presence and quantity of COVID-19 antibodies
News briefing: Exelixis rolls the dice with 2 ADC deals tied to $35M cash upfronts; A rare antibiotic win for prominently-backed Spero
Coronavirus nanoscience: the tiny technologies tackling a global pandemic
Early data shows Russia’s Sputnik V COVID-19 vaccine produces immune response
AbbVie Inks Deal To Develop, Sell I-Mab’s Cancer Therapy
Russia’s Covid-19 vaccine showed antibody response in initial trials
Researchers identify nanobody that may prevent COVID-19 infection